| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |